Come up with a name for your new list and we'll add to it:
Cellectar Biosciences raised a round of funding on April 15, 2011. Investors include
Wisconsin Investment Partners.
Cellectar Therapeutics, formerly Novelos Therapeutics, is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar's no…